Alaunos Therapeutics, Inc. (TCRT) Net margin 2016–2025
Alaunos Therapeutics, Inc. (TCRT) net profit margin by fiscal year — reported net income divided by reported revenue.
-83520.0%FY2025 · since FY2016: -2409.2% → -83520.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -83520.0% | -36730.0 pp |
| FY2024 | -46790.0% | +46790.0 pp |
| FY2023 | -93580.0% | -92288.8 pp |
| FY2022 | -1291.2% | +18495.4 pp |
| FY2021 | -19786.7% | — |
| FY2018 | -36381.5% | -35531.2 pp |
| FY2017 | -850.3% | +1559.0 pp |
| FY2016 | -2409.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice